Evaluation of the Rapid and Cartridge-Based STANDARD™ M10 STI Panel: Analytical and Clinical Performance for Multiplex STI Detection
Authors:
- Massimiliano GuerraMGMassimiliano Guerra
- Martina BrandoliniMBMartina Brandolini
- Laura DionisiLDLaura Dionisi
- Claudia ColosimoCCClaudia Colosimo
- Giulia GattiGGGiulia Gatti
- Alessandra Mistral De PascaliAPAlessandra Mistral De Pascali
- Endah IndriastutiEIEndah Indriastuti
- Ludovica InglettoLILudovica Ingletto
- Anna MarzuccoAMAnna Marzucco
- Maria Sofia MontanariMMMaria Sofia Montanari
- Laura GrumiroLGLaura Grumiro
- Giorgio DiraniGDGiorgio Dirani
Open Access
- 11 March 2026
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 14 (3) , 631
Abstract
Sexually transmitted infections (STIs) remain a major global public health concern, with more than one million new cases acquired daily and increasing antimicrobial resistance compromising effective control strategies. Rapid, accurate and multiplex molecular diagnostics are therefore essential to support timely clinical management and public health surveillance. This study evaluated the analytical and clinical performance of the cartridge-based STANDARD™ M10 STI Panel (SD Biosensor, Republic of Korea), a fully automated, random-access real-time PCR assay capable of detecting eight STI-related pathogens within approximately 64 min. A total of 150 residual clinical specimens were retrospectively analysed, including vaginal, rectal, urethral and oropharyngeal swabs, as well as seminal fluids, and results were compared with those obtained using the Allplex™ STI Essential Assay (Seegene, Republic of Korea), which shares six common targets. The STANDARD™ M10 STI Panel demonstrated high diagnostic accuracy, with sensitivity ranging from 89.5% to 100%, specificity from 98.2% to 100% and overall accuracy between 98% and 100%. Agreement between the two assays was almost perfect, with Cohen’s κ values ranging from 0.91 to 1.00. Analytical sensitivity was further confirmed through verification of the limits of detection using quantified reference standards. Although validated for urine samples, the assay also showed robust performance on alternative clinical matrices, particularly vaginal swabs. Overall, these findings indicate that the STANDARD™ M10 STI Panel represents a reliable and practical tool for STI diagnosis, combining rapid turnaround time, minimal hands-on requirements and broad pathogen coverage in both centralized and near-patient testing settings.Keywords
This publication has 28 references indexed in Scilit:
- WHO global research priorities for sexually transmitted infectionsThe Lancet Global Health, 2024
- Coinfections with multiple sexually transmitted pathogens in Republic of Korea, 2018–2020Journal of Clinical Laboratory Analysis, 2022
- Diagnosing sexually transmitted infections in resource‐constrained settings: challenges and ways forwardJournal of the International AIDS Society, 2019
- Identifying a consensus sample type to test for Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis and human papillomavirusClinical Microbiology and Infection, 2018
- Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society—Lancet CommissionThe Lancet, 2018
- Sexually transmitted infections: challenges aheadThe Lancet Infectious Diseases, 2017
- Methods to determine limit of detection and limit of quantification in quantitative real-time PCR (qPCR)Biomolecular Detection and Quantification, 2017
- Prevalence of sexually transmitted infections among healthy Korean women: Implications of multiplex PCR pathogen detection on antibiotic therapyJournal of Infection and Chemotherapy, 2014
- Carcinogenicity of human papillomavirusesThe Lancet Oncology, 2005
- PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settingsThe Lancet Infectious Diseases, 2004